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We recently reported in this journal that the
expression of adhesion molecules, including E-
selectin, ICAM-1 and VCAM-1, in human pulmonary
microvascular endothelial cells (PMVEC) induced by
TNF-a is inhibited significantly by pretreatment
with pyrrolidine dithiocarbamate (PDTC) or sper-
mine NONOate (Sper-NO), possibly in part through
blocking the activation of NF-kB.1 As demonstrated
by Blease et al. and others,2,3 human PMVEC are
capable of synthesizing chemokines such as IL-8,
monocyte chemotactic protein (MCP)-1 and regu-cts of PDTC (A) and Sper-NO (B) on the produc
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med.2005.01.011lated upon activation, normal T-cell expressed and
secreted (RANTES) upon a variety of pro-inflamma-
tory stimuli. However, redox-regulated mechanisms
of chemokine production in human PMVEC have
never been elucidated. We therefore evaluated the
impact of PDTC and Sper-NO on the production of
CC chemokines induced by TNF-a in human PMVEC.
Human PMVEC were cultured as described re-
cently.1 Cell suspensions (5 104 cells per well)
were seeded on 24-well culture clusters. After cells
reached confluence, human PMVEC were incubated
for 8 h in M199 medium alone or with 10 ng/ml TNF-
a in a final volume of 300 ml. In other wells, cells
were pretreated for 1 h in M199 medium with
0.1mM PDTC or 1mM Sper-NO; they were then
incubated in the same medium alone or with 10 ng/
ml TNF-a for 8 h. Cell-free supernatants from
resting or stimulated human PMVEC cultures were
tested for MCP-1, RANTES (Biosource International,tion of MCP-1, RANTES and eotaxin in TNF-a-stimulated
d with 0.1mM PDTC or 1mM Sper-NO for 1 h; thereafter,
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contents by sandwich ELISA kits according to the
manufacturers’ protocols.
Figure 1 shows that treatment of human PMVEC
with TNF-a for 8 h resulted in a significant increase
in the production of MCP-1, RANTES and eotaxin, as
compared to the non-stimulated cells. Of note,
pretreatment for 1 h with PDTC or Sper-NO sig-
nificantly inhibited the production of MCP-1,
RANTES and eotaxin induced by TNF-a.
Chemokines are divided into the CXC, CC, C and
CX3C subfamilies. Of these, CC chemokines are
most diversified and act on monocytes, activated T-
cells, eosinophils and basophils.4 The NF-kB plays
an important role in the gene regulation of
chemokines, including MCP-1, RANTES and eotaxin.
As shown in our recent paper, PDTC and Sper-NO
inhibit NF-kB activation in human PMVEC.1 It was
reported that PDTC inhibits the production of IL-8,
MCP-1 and RANTES in human umbilical vein
endothelial cells and pancreatic periacinar myofi-
broblasts through a blockade of NF-kB activation.5,6
NO suppresses the production of MCP-1 and RANTES
in human umbilical vein endothelial cells and
keratinocyte cell line HaCaT.7,8
Our recent1 and present findings indicate that
both adhesion molecule expression and chemokine
production in human PMVEC induced by TNF-a are
inhibited significantly by pretreatment with PDTC
or Sper-NO, possibly via blocking redox-regulated
NF-kB activation. These results suggest that re-
storation of the redox balance using antioxidants or
NO may offer potential therapeutic approach in
cytokine-mediated inflammatory reactions in the
human lung.References
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